BSE Live
Oct 01, 16:01Prev. Close
47.92
Open Price
48.07
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
NSE Live
Oct 01, 15:59Prev. Close
47.85
Open Price
48.13
Bid Price (Qty.)
48.81 (17871)
Offer Price (Qty.)
0.00 (0)
Balance Sheet of Morepen Laboratories (in Rs. Cr.) | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 | |
12 mths | 12 mths | 12 mths | 12 mths | 12 mths | ||
EQUITIES AND LIABILITIES | ||||||
SHAREHOLDER'S FUNDS | ||||||
Equity Share Capital | 109.58 | 102.23 | 102.23 | 95.56 | 89.96 | |
Total Share Capital | 109.58 | 102.23 | 102.23 | 95.56 | 89.96 | |
Reserves and Surplus | 1,071.92 | 786.80 | 677.89 | 502.61 | 311.26 | |
Total Reserves and Surplus | 1,071.92 | 786.80 | 677.89 | 502.61 | 311.26 | |
Total Shareholders Funds | 1,181.50 | 889.02 | 780.11 | 598.17 | 401.22 | |
NON-CURRENT LIABILITIES | ||||||
Long Term Borrowings | 25.76 | 3.36 | 0.93 | 1.32 | 0.83 | |
Deferred Tax Liabilities [Net] | 6.98 | 2.25 | 2.69 | 2.48 | 0.00 | |
Other Long Term Liabilities | 9.02 | 0.43 | 1.97 | 1.96 | 2.05 | |
Long Term Provisions | 36.40 | 31.60 | 28.87 | 26.64 | 24.01 | |
Total Non-Current Liabilities | 78.15 | 37.65 | 34.45 | 32.41 | 26.89 | |
CURRENT LIABILITIES | ||||||
Short Term Borrowings | 53.20 | 24.83 | 24.23 | 17.25 | 15.32 | |
Trade Payables | 338.41 | 267.43 | 213.10 | 217.32 | 192.33 | |
Other Current Liabilities | 52.34 | 37.33 | 38.73 | 158.51 | 164.37 | |
Short Term Provisions | 17.60 | 23.05 | 14.91 | 9.61 | 3.60 | |
Total Current Liabilities | 461.56 | 352.64 | 290.98 | 402.69 | 375.63 | |
Total Capital And Liabilities | 1,721.20 | 1,279.31 | 1,105.54 | 1,033.26 | 847.50 | |
ASSETS | ||||||
NON-CURRENT ASSETS | ||||||
Tangible Assets | 332.31 | 212.44 | 166.09 | 145.44 | 127.89 | |
Intangible Assets | 33.57 | 4.09 | 4.74 | 10.67 | 16.14 | |
Capital Work-In-Progress | 28.34 | 24.45 | 17.01 | 14.15 | 1.96 | |
Other Assets | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Fixed Assets | 394.21 | 240.99 | 187.83 | 170.26 | 145.98 | |
Non-Current Investments | 127.17 | 126.18 | 117.84 | 117.79 | 118.78 | |
Deferred Tax Assets [Net] | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Long Term Loans And Advances | 0.14 | 0.04 | 0.05 | 0.06 | 0.06 | |
Other Non-Current Assets | 92.90 | 69.20 | 68.97 | 68.39 | 89.89 | |
Total Non-Current Assets | 614.42 | 436.40 | 374.69 | 356.50 | 354.71 | |
CURRENT ASSETS | ||||||
Current Investments | 77.81 | 0.00 | 0.00 | 0.00 | 0.00 | |
Inventories | 286.39 | 220.15 | 211.35 | 258.25 | 169.61 | |
Trade Receivables | 293.75 | 316.89 | 255.47 | 221.87 | 155.52 | |
Cash And Cash Equivalents | 46.33 | 50.48 | 55.90 | 45.55 | 66.98 | |
Short Term Loans And Advances | 0.48 | 0.22 | 0.27 | 0.34 | 0.27 | |
OtherCurrentAssets | 402.03 | 255.17 | 207.85 | 150.75 | 100.41 | |
Total Current Assets | 1,106.78 | 842.91 | 730.85 | 676.76 | 492.79 | |
Total Assets | 1,721.20 | 1,279.31 | 1,105.54 | 1,033.26 | 847.50 | |
OTHER ADDITIONAL INFORMATION | ||||||
CONTINGENT LIABILITIES, COMMITMENTS | ||||||
Contingent Liabilities | 35.68 | 20.04 | 11.84 | 18.98 | 3.36 | |
CIF VALUE OF IMPORTS | ||||||
Raw Materials | 592.67 | 525.53 | 413.27 | 495.55 | 352.40 | |
Stores, Spares And Loose Tools | 7.69 | 15.00 | 19.13 | 83.89 | 69.25 | |
Trade/Other Goods | 7.69 | 15.00 | 19.13 | 83.89 | 69.25 | |
Capital Goods | 9.62 | 5.74 | 0.77 | 2.28 | 1.22 | |
EXPENDITURE IN FOREIGN EXCHANGE | ||||||
Expenditure In Foreign Currency | 16.47 | 12.18 | 11.17 | 8.84 | 7.56 | |
REMITTANCES IN FOREIGN CURRENCIES FOR DIVIDENDS | ||||||
Dividend Remittance In Foreign Currency | -- | -- | -- | -- | -- | |
EARNINGS IN FOREIGN EXCHANGE | ||||||
FOB Value Of Goods | 664.03 | 638.76 | 565.66 | 551.35 | 474.09 | |
Other Earnings | -- | -- | -- | -- | -- | |
BONUS DETAILS | ||||||
Bonus Equity Share Capital | -- | -- | -- | -- | -- | |
NON-CURRENT INVESTMENTS | ||||||
Non-Current Investments Quoted Market Value | -- | -- | -- | -- | 1.31 | |
Non-Current Investments Unquoted Book Value | 127.20 | 126.18 | 117.84 | 117.79 | 117.69 | |
CURRENT INVESTMENTS | ||||||
Current Investments Quoted Market Value | 79.87 | -- | -- | -- | -- | |
Current Investments Unquoted Book Value | -- | -- | -- | -- | -- |
12.08.2025
Morepen Lab Consolidated June 2025 Net Sales at Rs 425.24 crore, down 6.59% Y-o-Y
07.08.2025
Morepen Lab Standalone June 2025 Net Sales at Rs 391.28 crore, up 1.46% Y-o-Y
13.05.2025
Morepen Lab Standalone March 2025 Net Sales at Rs 381.94 crore, down 2.72% Y-o-Y
12.05.2025
Morepen Lab Consolidated March 2025 Net Sales at Rs 465.85 crore, up 10.11% Y-o-Y